Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers acute care, specialist-orientated, and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 17 private acute care hospitals and 4 clinics with approximately 1,805 inpatient beds in Switzerland; 49 acute care private hospitals and 2 day clinics in South Africa, and 3 hospitals in Namibia with approximately 8,131 inpatient beds; and 6 acute care private hospitals and 22 clinics with approximately 748 inpatient beds in the United Arab Emirates. The company also provides treasury, hospital equipment, debt collection and related, emergency medical, management, food and catering, procurement, and healthcare management services; manages healthcare staff; and owns and manages properties. In addition, it engages in intellectual property holding and medical store/procurement businesses. Mediclinic International plc was founded in 1983 and is based in Stellenbosch, South Africa.
Industry, Sector and Symbol
Industry Medical Care
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+44-20-79549600
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales£2.85 billion
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date5/23/2019 (Estimated)
OptionableOptionable
Mediclinic International (LON:MDC) Frequently Asked Questions
What is Mediclinic International's stock symbol?
Mediclinic International trades on the London Stock Exchange (LON) under the ticker symbol "MDC."
How often does Mediclinic International pay dividends? What is the dividend yield for Mediclinic International?
Mediclinic International declared a dividend on Thursday, November 15th. Shareholders of record on Thursday, December 6th will be paid a dividend of GBX 3.20 per share on Tuesday, December 18th. This represents a yield of 0.93%. The ex-dividend date of this dividend is Thursday, December 6th. The official announcement can be viewed at this link. View Mediclinic International's Dividend History.
When is Mediclinic International's next earnings date?
What price target have analysts set for MDC?
5 brokerages have issued 1 year target prices for Mediclinic International's shares. Their forecasts range from GBX 360 to GBX 550. On average, they expect Mediclinic International's share price to reach GBX 441 in the next twelve months. This suggests a possible upside of 40.0% from the stock's current price. View Analyst Price Targets for Mediclinic International.
What is the consensus analysts' recommendation for Mediclinic International?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mediclinic International in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Mediclinic International.
Has Mediclinic International been receiving favorable news coverage?
Media stories about MDC stock have been trending somewhat negative recently, according to InfoTrie. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Mediclinic International earned a news impact score of -1.4 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the near term.
Who are some of Mediclinic International's key competitors?
Some companies that are related to Mediclinic International include NMC Health (NMC), Healius (HLS), Rhoen Klinikum (RHK), Greencross (GXL), Spire Healthcare Group (SPI), CareTech (CTH), Virtus Health (VRT), Georgia Healthcare Group (GHG), Pacific Smiles Group (PSQ), Assure (IOM), CENTRIC HEALTH (CHH), Nobilis Health (HLTH), Konekt (KKT), Brain Resource (BRC) and Totally (TLY).
What other stocks do shareholders of Mediclinic International own?
Who are Mediclinic International's key executives?
Mediclinic International's management team includes the folowing people:
- Mr. Petrus Jurgens Myburgh, Group CFO & Exec. Director (Age 44)
- Mr. Ronnie van der Merwe, CEO & Exec. Director
- Dr. Dirk C. Le Roux, Chief Information Officer (Age 59)
- Mr. James Arnold, Head of Investor Relations
- Mr. Magnus U. Oetiker, Chief HR Officer (Age 47)
How do I buy shares of Mediclinic International?
Shares of MDC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Mediclinic International's stock price today?
One share of MDC stock can currently be purchased for approximately GBX 315.
How big of a company is Mediclinic International?
Mediclinic International has a market capitalization of £2.32 billion and generates £2.85 billion in revenue each year.
What is Mediclinic International's official website?
How can I contact Mediclinic International?
Mediclinic International's mailing address is 6th Floor 65 Gresham Street, LONDON, EC2V 7NQ, United Kingdom. The company can be reached via phone at +44-20-79549600.
MarketBeat Community Rating for Mediclinic International (LON MDC)
MarketBeat's community ratings are surveys of what our community members think about Mediclinic International and other stocks. Vote "Outperform" if you believe MDC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDC will underperform the S&P 500 over the long term. You may vote once every thirty days.
